Latif Nasser

That's it.

And you're done and you've cured somebody.

So he says, this is a one-time deal.

This is like one-time $84,000.

And then you're done.

Think about all the years you'll live without having an illness.

Then you'll see.

Over a 20-year period, the savings that will accrue to the system by having a patient cured of hepatitis C.

He also said it's important to understand that every hepatitis C sufferer is not going to hit the system at the same time.

So all of the cost is spread out, right?

Which is totally true, but I think there's like this bigger picture here.

And Bruce points it out too.

And then you're talking tens of millions of people.

Even if just a fraction of them want a drug that's $1,000 per day, that's practically our entire U.S.

budget.

This is the part where I really sort of got hooked in, where it's like, how do you answer this question?

Is it that, you know, at a certain point you just draw a line and you say, beyond this point, we're not paying.

But beyond what point?

Exactly.

I mean, that's the hard part.